IMAGE: An Auxiliary Nurse Midwife healthcare worker inoculating a beneficiary with a dose of the COVID-19 vaccine during a door to door vaccination campaign at Margomunda, in Deoghar, Jharkhand,......
An expert panel of India's central drug authority on Saturday recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine Covaxin with certain......
Bharat Biotech has sought the Drug Controller General of India's approval to conduct phase-3 trials of its COVID-19 intranasal vaccine (BBV154) to use as booster dose, sources said on Monday.......
After Pfizer and Serum Institute, Hyderabad-based pharmaceutical firm Bharat Biotech on Monday applied to the central drug regulator seeking emergency use authorisation for its COVID-19 vaccine......
The Drugs Controller General of India on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed COVID-19 vaccine with certain conditions, officials said.......
'We need to prove to the world that quality vaccines and R&D are possible in India.' *Photograph: Carl Recine/Reuters. Dr Krishna Ella, chairman and MD, Bharat Biotech, is the man of the moment.......